Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D001431:Bacteriological Techniques; D001770:Blood Bactericidal Activity; D003165:Complement System Proteins; D004492:Edetic Acid; D006801:Humans; D007106:Immune Sera / Q000032:analysis; D007962:Leukocytes / Q000276:immunology*; D009895:Opsonin Proteins; D010587:Phagocytosis; D011552:Pseudomonas Infections / Q000276:immunology*; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D018805:Sepsis / Q000276:immunology; D012911:Snakes; D014688:Venoms
D000906:Antibodies; D007106:Immune Sera; D009895:Opsonin Proteins; D014688:Venoms; D003165:Complement System Proteins; D004492:Edetic Acid